The ubiquitin (Ub)-proteasome system (UPS) promotes the proteasomal degradation of target proteins by decorating them with Ub labels. Emerging evidence indicates a role of UPS in regulating gene transcription. In this study, we provided evidence for the involvement of UPS in the transcriptional activation function of tumor suppressor p53. We showed that both ubiquitylation and proteasomal functions are required for efficient transcription mediated by p53. Disruption of transcription by actinomycin D, 5,6-dichloro-1-b-D-ribofuranosyl-benzimadazole or a-amanitin leads to accumulation of cellular p53 protein. Proteasome inhibition by MG132 increases the occupancy of p53 protein at p53-responsive p21 waf1 promoter. In addition, the Sug-1 component of 19S proteasome physically interacts with p53 in vitro and in vivo. Moreover, in response to ultraviolet-induced DNA damage, both the 19S proteasomal components, Sug1 and S1, are recruited to p21 waf1 promoter region in a kinetic pattern similar to that of p53. These results suggested that UPS positively regulates p53-mediated transcription at p21 waf1 promoter.
Introduction
In eukaryotic cells, the ubiquitin (Ub)-proteasome pathway (UPS) involves Ub modification and subsequent degradation of protein substrates. UPS controls the levels of many cellular regulatory proteins, including transcription factors, cell cycle regulatory proteins and factors participating in a variety of cellular processes (Glickman and Ciechanover, 2002) . Recent approval of proteasome inhibitor Velcade for clinical trial signifies the importance of UPS for cancer development (Adams and Kauffman, 2004) . The common feature of UPS pathway is that the highly conserved Ub is covalently attached to the target proteins through a series of enzymes, namely E1 Ub-activating enzyme, E2 Ubconjugating enzyme and E3 Ub ligase. The E1 first activates Ub and transfers it to E2. From the E2 enzyme, the Ub is transferred directly to the target protein or indirectly through an E3 Ub ligase (Varshavsky, 1997) . The polyubiquitylated protein is recognized and degraded by 26S proteasome, a large complex with multiple proteolytic activities (Varshavsky, 1997; Glickman and Ciechanover, 2002) .
The proteins destructed by Ub-mediated proteolysis usually contain elements that signal their ubiquitylation. These elements are often portable and referred to as degrons (Varshavsky, 1997) . The degrons have been found to overlap transcriptional activation domains (TADs) of transcription factors (Molinari et al., 1999; Salghetti et al., 2000; Wang et al., 2000) . The extent of Ub-mediated proteasomal degradation was found to correlate with the potency of the TADs (Salghetti et al., 2000) . Such convergence of the transcriptional activation and the proteolytic signaling raises the possibility that the Ub-proteasome pathway could be involved in transcriptional activation. Emerging evidence indicates that proteasomal components are directly involved in transcriptional regulation. It has been demonstrated that several components of 19S proteasomal regulatory particle (also referred to as 19S proteasome) associate directly with the yeast Gal4 activator and are recruited to activated GAL promoter (Gonzalez et al., 2002) . In addition, the 19S proteasome has also been shown to be critical for efficient transcription elongation by RNA polymerase II (Ferdous et al., 2001) . Furthermore, 26S proteasome physically and functionally associates with RNA polymerase II (Gillette et al., 2004) . In mammals, the proteasome participates in transcriptional activation by retinoic acid (Gianni et al., 2002) and estrogen receptor (Reid et al., 2003) . It has also been found that ubiquitylation of synthetic transcriptional activator is required for its transcription both in Saccharomyces cerevsiae and in mammalian cells (Salghetti et al., 2001; Zhu et al., 2004) . In another case, turnover of yeast transcription regulator GCN4 is suggested to play a putative stimulatory role in expression of its downstream genes (Lipford et al., 2005) . Although the general molecular basis for UPS in transcription is still unclear, a growing number of Ub ligases including RSP5 (Imhof and McDonnell, 1996) , E6-AP (Nawaz et al., 1999) , Tom1 (Saleh et al., 1998) and p300 (Grossman et al., 2003) have been demonstrated to have transcriptional co-activator activity.
The tumor suppressor p53 is one of those mammalian transcription factors, whose TADs overlap degrons (Salghetti et al., 2000) . The p53 plays a crucial role in coordinating the cellular response to genotoxic stress (Hartwell and Kastan, 1994; Levine, 1997) . p53 regulates the expression of many downstream effectors involved in cell growth, cell cycle arrest and apoptosis (El-Deiry, 1998) . The cellular levels of p53 protein are tightly regulated through UPS (Haupt et al., 1997; Kubbutat et al., 1997) . Early studies suggested that oncoprotein MDM2 is a primary E3 Ub ligase for p53 degradation (Haupt et al., 1997; Kubbutat et al., 1997) . MDM2 itself is transcriptionally activated by p53 and it regulates p53 in a negative feedback loop (Wu et al., 1993) . Recent studies, however, revealed a multiple facet of regulation of p53 by UPS. Besides MDM2, several E3 Ub ligases (e.g. E6AP, MDMX, COP1, Pirh2, ARF-BP1, topors and BRCA1-BARD1) were identified to be involved in p53 degradation (Brooks and Gu, 2006) .
To investigate whether turnover of p53 by UPS plays a role in gene expression, we examined the influence of UPS on p53-mediated transcription. We showed that both ubiquitylation and proteasomal functions are required for the efficient transcription mediated by p53. The proteasome-mediated degradation is partially dependent on transcription. We further demonstrated the in vitro and in vivo physical interaction between p53 protein and Sug-1 component of 19S proteasome and the recruitment of both p53 and proteasome components to p21 waf1 promoter region. These results uncovered a positive regulatory role of UPS in p53-mediated transcription.
Results
Proteasomal inhibition blocks p53 degradation whereas attenuates p53-mediated transcription Earlier observations showed that in proteasome-inhibited cells, p53 does not efficiently transactivate either p21 waf1 or MDM2, although p53 protein accumulates and can still bind to oligonucleotides encoding p53 binding site of p21 waf1 promoter (Siliciano et al., 1997) . In the light of recently revealed stimulatory role of activator turnover in gene expression, we wished to examine the impact of proteasome inhibition on the transcription driven by p53 protein. As shown in Figure 1 , steady-state level of wild-type p53 protein was undetectable in normal human fibroblast (NHF).
However, proteasome inhibitor MG132 treatment significantly increased p53 level (Figure 1a) . Concurrently, luciferase expression driven from the p53 responsive reporter pG13-Luc, in the presence of MG132, decreased to about 25-30% of vehicle-treated controls. The MG132 treatment did not alter either the level of actin or the transcription driven from a cytomegalovirus (CMV) promoter, indicating that transcriptional impact of proteasome inhibition is activator specific. We further examined the effect of MG132 on the transcription mediated by ectopically expressed p53 protein. The p53-Null Li-Fraumeni syndrome (LFS) cells co-transfected with a p53 expression construct and pG13-Luc reporter were treated with MG132 or its vehicle as a control. The transcription driven by the viral CMV promoter in LFS cells showed a slight decrease, probably due to the toxicity of MG132 in these cells. Again, MG132 attenuated p53-mediated transcription while elevating the protein level of p53 ( Figure 1b) .
We detected mRNA of p53 downstream genes DDB2, MDM2 and p21 waf1 under the influence of MG132 using reverse transcription-polymerase chain reaction (RT-PCR). MG132 attenuated mRNA level of DDB2, MDM2 and p21 waf1 ( Figure 1c ). It did not affect the expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). As expected, DNA damage by ultraviolet (UV) increased the mRNA levels of these p53 downstream genes. MG132, however, decreased the upregulated mRNA in a dose-dependent manner but did not change the expression of GAPDH. These results indicated that the p53-mediated transcription of its downstream gene is impaired as a result of the proteasome inhibition. Thus, we hypothesize that proteasome function is required for efficient transcription mediated by p53.
We next examined the impact of proteasome inhibition on synthetic activators containing p53 TAD, which is located in the N-terminal (1-42 aa) of the p53 protein.
This segment also signals Ub-mediated p53 degradation (Haupt et al., 1997) . The vectors for fusion protein of GAL4 DNA-binding domain in-frame with either the full length or TAD of p53 were transfected into LFS cells along with a GAL4-responsive reporter and then subjected to treatment with MG132. Proteasome inhibition attenuated transcription mediated by both fusion proteins (Figure 1d ), indicating that proteasome function is required for efficient transcription driven through the p53 TAD.
Disruption of function of Ub-activating enzyme (E1) causes a decrease in p53-mediated transcription To address whether the ubiquitylation process plays any role in p53-mediated transcription, transfection and reporter assays were performed in ts85 cells harboring a temperature-sensitive mutation in E1 Ub-activating enzyme, which leads to a defect in ubiquitylation at the restrictive temperature (Finley et al., 1984) . A shift from permissive (321C) to restrictive (371C) temperature leads to a five-to eightfold decrease in transcription from p53 reporter pG13-luc, but does not affect transcription from pCMV-luc reporter ( Figure 2a) . The same treatment, however, caused a significant increase in steady-state level of endogenous p53 protein ( Figure 2b ). These results demonstrate that disruption of ubiquitylation does not have a severe effect on general transcription, but specifically compromises p53-mediated transcription. Additionally, UV irradiation resulted in a Bthreefold increase in p53-mediated transcription at the permissive temperature. However, at restrictive temperature, p53-mediated transcription is compromised in ts85 cells (Figure 2c ). Furthermore, UV failed to increase p21 waf1 levels in ts85 cells at either 32 or 371C, although a pronounced p53 accumulation was observed at 371C ( Figure 2d ). The failure of UV to increase p21 waf1 levels at 321C suggested that the E1 in ts85 cells may not be fully active at this temperature. These results indicated that p21 waf1 expression is very sensitive to E1 dysfunction. By contrast, DNA damage induced p53 accumulation and subsequent increase in p21 waf1 protein in parental FM3A cells. These results again indicated that ubiquitylation is also required for Figure 1 Proteasomal inhibition compromises p53-mediated transcription. (a) NHFs were transiently transfected with 0.5 mg each of p53-responsive reporter pG13-luc, a CMV promoter-driven luciferase construct pCMV-luc or empty pcDNA3 vector for 12 h. After transfection, the cells were treated with proteasome inhibitor MG132 or its vehicle dimethyl sulfoxide (DMSO) for another 12 h and harvested for luciferase assay or Western blotting analysis. The percentage of luciferase activity in MG132-treated cells vs that in DMSO-treated controls was calculated to show the relative activation/inhibition. (b) p53-Null LFS fibroblasts were co-transfected with 0.5 mg each of pG13-luc and p53 expression vector. The transfection, MG132 treatment, luciferase assay and Western analysis were carried out as described for Figure 1a . (c) NHFs were either unirradiated or UV irradiated at a dose of 10 J/m 2 . Twelve hours after UV irradiation, the cells were treated with 0, 5 or 25 mM MG132 for additional 8 h. Total RNA were then isolated from the treated cells and mRNA of DDB2, human MDM2, p21 waf1 and GAPDH were detected by RT-PCR assay using gene specific primers as described in 'Materials and methods'. (d) The LFS fibroblasts were transfected with 1 mg each of the pG5-luc GAL4 responsive reporter and 1 mg of GAL4 DNA BD construct, pBIND or GAL4-p53 or GAL4-p53 (1-42 aa). The fold activation was calculated according to the luciferase activities from GAL4-p53 or GAL4-p53-transfected cells in relation to the activities from pBIND-transfected cells.
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Inhibition of transcription leads to p53 accumulation
To ask whether p53 turnover is intrinsically linked to transcription, we assessed the effect of transcription inhibition on p53 response to UV-induced DNA damage during the extended post-irradiation period when low p53 levels are re-established via Ub-mediated proteolysis. In NHF, p53 peaked at 8-h post-UV irradiation. By 72 h, p53 level was still detectable but significantly lower than that at 8 h (Figure 3a) . During 48-72-h period, transcription inhibitor actinomycin D (ActD), 5,6-dichloro-1-b-D-ribofuranosyl-benzimadazole (DRB) or a-amanitin treatment prevented the loss of p53 in a dose-dependent manner (Figure 3a-c) , indicating that degradation of p53 is sensitive to transcription inhibition. The p53 re-accumulation during transcription inhibition, observed under these conditions, could not be due to impairment of UPS for the following reasons. First, p53 degradation occurs in the tested time frame in the absence of any transcription inhibition; second, DRB and a-amanitin at their lower concentrations did not significantly affect the level of p21 waf1 ; third, the p53-MDM2 regulatory loop remains uninfluenced by DRB-induced transcription inhibition (Ljungman et al., 1999; O'Hagan and Ljungman, 2004) , Therefore, it can be inferred that the degradation of p53 is intrinsically linked to transcription.
We further examined whether transcription inhibitors alter the p53 ubiquitylation. The wild-type p53-containing human breast adenocarcinoma MCF-7 cells were treated with transcription inhibitors and p53 Ub conjugates were detected by Western blotting after immunoprecipitation. In Figure 3d , treatment of transcription inhibitors at their higher concentration caused an apparent accumulation of Ub conjugates of p53, despite producing a more intensive signal in MG132-treated cells. The Ub conjugates in transcription inhibitor-treated cells were in molecular size larger than 100 kDa, indicating that they were polyubiquitylated p53 proteins. The Ub conjugate signals were observable with DRB treatment at its lower concentration, suggesting that DRB is more effective in accumulating Ub conjugates of p53. These results, consistent with earlier observation (O'Hagan and Ljungman, 2004) , indicated that transcription inhibition causes moderate accumulation of ubiquitylated p53 proteins. (Ferdous et al., 2001; Gonzalez et al., 2002; Gillette et al., 2004) . The Sug-1, one of the six AAA ATPase complex in the base of 19S (Glickman et al., 1998; DeMartino and Slaughter, 1999) , is known to directly bind to TAD of GAL4, viral activator VP16 and thyroid-hormone and retinoid-X receptors (Lee et al., 1995; Swaffield et al., 1995; vom Baur et al., 1996) . We therefore tested the interactions between p53 protein and Sug-1 component.
As shown in Figure 4a and b, bacterial expressed Sug-1 and the C-terminal segment of Sug-1 (C.hSug-1) retained both p53 and the XPB component of transcription factor II H, whereas Sug-1mk mutant (K196M), N-terminal segment of Sug-1 (N.hSug-1) and glutathione S-transferase (GST) itself did not. As the K196M mutation abolishes ATPase activity of Sug-1, these results further suggested that the ATPase module is crucial for interaction. In addition, p53 protein was co-immunoprecipitated from UV-irradiated NHF extracts by anti-Sug-1 antibody but not by control normal human IgG or anti-XPB antibody, indicating that p53 and Sug-1 physically associate in vivo (Figure 4c ). The anti-Sug-1-co-immunoprecipitated p53 and GSThSUG-associated p53 appeared to be of the same molecular size as p53 itself, suggesting that the interaction between p53 and Sug-1 is not dependent on polyubiquitylation of p53. We envisage that p53 associates with the proteasome or its subcomplex through p53-Sug-1 interaction.
Recruitment of p53 and proteasomal components S1 and Sug-1 to p21 waf1 promoter in vivo To determine whether the inhibition of proteasome affects the association of p53 with an endogenous promoter, we assessed the recruitment of p53 to p21 waf1 promoter. As shown in Figure 5a , the wild-type p53-containing MCF-7 cells had a detectable p53 level, which promptly responds to UV-induced DNA damage. MG132 treatment increased the p53 accumulation triggered by UV irradiation. Chromatin immunoprecipitation (ChIP) assays revealed a distinct recruitment of p53 at p21 waf1 promoter that was visible as early as 2 h in UVirradiated cells. The p53 occupancy peaked at 12 h and the level sustained up to 24 h. These in vivo kinetic data of p53's binding to p21 waf1 promoter region are consistent with published results (Szak et al., 2001) . As a small fraction of protein would be in its unstable ubiquitylated forms, the majority of ChiP-recovered p53 proteins are presumably non-ubiquitylated proteins. Our data further showed that MG132 increased the p53 occupancy of p21 waf1 promoter at 2-12-h period but had little effect at later time points. These results clearly indicated that proteasome inhibition increases p53 occupancy rather than impairs its binding to p21 waf1 promoter in vivo. To test whether proteasome is directly participating in p53-mediated transcription, we probed the binding of proteasome to p53-binding sequence of p21 waf1 promoter p53 Degradation in transcriptional activation Q Zhu et al using ChIP assay and the antibodies against the S1 and Sug-1 proteasomal components. The recruitment of Sug-1 to p21 waf1 promoter region was not seen in non-UV-irradiated cells, but became visible within 2 h of UV exposure (Figure 6a ). The Sug-1 recruitment peaked at 12 h and persisted up to 24 h. The pattern of Sug-1 recruitment was essentially similar to that of p53, suggesting that the Sug-1 recruitment is dependent on p53. The ChIP assay on S1 component showed that S1 was also recruited to the same p21 waf1 promoter region in a comparable pattern to that of Sug-1 (Figure 6a) , suggesting that the recruitment of S1 is also p53 dependent. Interestingly, MG132 caused a pronounced increase in Sug-1 and S1 occupancy of p21 waf1 promoter region during the initial 12-h post-irradiation period (Figure 6a) . Notably, MG132 did not affect the cellular waf1 by proteasomal components hSug1 and S1. (a) Recruitment of proteasomal components Sug1 and S1 to p21 waf1 promoter region was determined by PCR amplification of the p53-binding consensus DNA sequence using ChIP assay. The MCF-7 cells were UV irradiated, MG132 treated and the chromatin extracts processed as described in Materials and methods. (b) MG132 does not affect the protein levels of Sug1 and S1. The MCF-7 cells were UV irradiated and MG132 treated as described for Figure 5a . The UV and proteasome inhibitortreated cells were collected and cell extracts were made and analysed by immunoblotting for Sug-1 and S1 components of proteasome. Figure 4 p53 binds proteasomal component Sug1 in vitro and in vivo. (a) Diagram shows Sug1 and its mutants used for GST pull-down assays. Constructs hSug1, N.hSug1, C.hSug1 contain the full-length human Sug1 and its N-terminal and C-terminal truncated segments, respectively. The hSug1mk contains a fulllength human Sug1 with a point mutation, which replaces the lysine residue at position 196 with a methionine residue. (b) Whole-cell extracts made from UV-irradiated NHFs were incubated with GST fusion protein-loaded glutathione sepharose 4B beads. The bound proteins were recovered and separated by SDS/PAGE and detected by Western blotting using the anti-p53 or XPB antibodies. (c) Immunoprecipitation was carried out using whole cell extracts made from UV-irradiated NHFs and 2 mg of normal rabbit IgG, 1 mg of anti-hSug1, and anti-XPB or anti-p53 antibody. The immunoprecipitates were captured by protein G plus/A agarose beads and presence of p53 proteins in the immunoprecipitates was examined by Western blotting. waf1 evaluated by ChIP assay. MCF-7 cells were UV irradiated and MG132 treated as that described for Figure 5a . The cells were then fixed for 10 min with 1% formaldehyde. The chromatin extracts were made from the fixed cells and the binding of p53 to p21 waf1 promoter were determined by ChIP followed by PCR detection of the genomic DNA of p21 waf1 promoter region as described in 'Materials and methods'. The figure shows the representative results from three independent experiments. p53 Degradation in transcriptional activation Q Zhu et al abundance of either Sug-1 or S1 proteins ( Figure 6b ). As S1 and Sug-1 belong to the lid and the base of 19S proteasome, respectively, these results indicated that the entire 19S proteasomal regulatory particle is recruited to p21 waf1 promoter region in a p53-dependent manner during p53-mediated transcription.
Discussion
UPS targets p53 to play a dual role in p53-mediated transcription and p53 degradation In this study, we demonstrated that UPS plays an important role in p53-mediated transcription. We also showed that 19S proteasome is recruited to p21 waf1 promoter via direct interaction with p53. These results suggest that the UPS does not simply limit p53 abundance for cellular regulation of p53 transcriptional activity but is directly involved in p53-mediated transcription.
Transcription mediated by transcription factors including p53, is an immensely complex process, which depends on RNA polymerase II, general and genespecific transcription factors as well as mediators (Roeder, 1996; Conaway et al., 2000; Dvir et al., 2001; Malik and Roeder, 2005) . In general, a transcription process includes several successive steps: open complex formation, transcription initiation, promoter escape and RNA polymerase II elongation. During the step of promoter escape, RNA polymerase is released from the promoter to execute elongation. The factors remaining at the promoter region may fire another round of transcription or the pre-initiation complex may be dissolved and the transcription cycle restarted. Observations presented in this study add another dimension to the complex process of transcription particularly the one mediated by p53. In simple terms, the explanation for the requirement of both ubiquitylation and proteasome function, through direct involvement of 19S proteasome in p53-mediated transcription, is that the degradation of promoter-bound p53 by UPS is critical for positive transcription regulation. It has been reported that p53 in proteasome-inhibited cells does not efficiently transactivate p21 waf1 or MDM2, although it is still capable of binding to oligonucleotides encoding p21 waf1 promoter. In current study, we observed that the proteasome inhibitor MG132 attenuated p53-regulated expression of DDB2, MDM2 and p21 waf1 in both UV and non-UVirradiated NHF (Figure 1c) . We also showed that proteasome inhibition impairs transcription from a synthetic promoter, which is exclusively driven by p53. In addition, proteasome function is required for efficient transcription driven by GAL4 synthetic activators containing p53 TAD. These results strongly suggested that p53-mediated transcription is functionally associated to UPS through p53 TAD. The results further showed that proteasome inhibition increases rather than decreases p53 occupancy of p21 waf1 promoter. It seems that promoter-bound p53 could not repeatedly and efficiently fire off new rounds of transcription, suggesting that p53-mediated transcription would operate via a mechanism, which requires ubiquitylation and proteasome function. Although such a 'single shot' mechanism has been put forward to explain how UPS regulates transcription (Lipford and Deshaies, 2003; Muratani and Tansey, 2003) , it is not yet fully clear. Indirect suggestion imply that proteasome inhibition prevents cycling of the estrogen receptor-a at its promoter site (Reid et al., 2003) . Nevertheless, estrogen receptor-a is not the only transcription factor whose turnover continuously takes place on DNA. Nuclear factor kB (Saccani et al., 2001 ) and p53 (Szak et al., 2001) have also been found to associate cyclically with their cognate promoters.
The involvement of the 19S proteasome in transcription has been described in yeast (Ferdous et al., 2001 (Ferdous et al., , 2002 . Our previous work demonstrated that the 19S proteasome associates with transcription factor II H (Zhu et al., 2004) . Here, we showed the in vitro and in vivo interaction between the proteasomal Sug-1 and p53 (Figure 4) . Furthermore, both Sug-1 and S1 are recruited to the p21 waf1 promoter with the kinetics similar to that of p53. These results strongly suggest that proteasome is involved in p53-mediated transcription. It is possible that the specific transcription factors, including p53, are responsible for the recruitment of the proteasome or its subcomplex to transcriptional machinery. At present, our data cannot distinguish between the involvements of 19S proteasome complex or entire 26S proteasome. We were unable to detect the presence of 20S proteasome components at p21 waf1 promoter using ChIP assay (data not shown). However, we are uncertain about technical limitation of ChIP assay. Gillette et al. (2004) have recently showed that proteasome physically and functionally associate with RNA polymerase II and the 26S proteasome recruits to coding regions including 3 0 ends of GAL4, GAL10 and HSP80 in a transcription-dependent manner. As the proteolytic function is required for efficient transcription mediated by p53, it is possible that proteasome works in both proteolysis-independent and -dependent manner at different stages of p53-mediated transcription.
An obstacle for understanding the role of UPS in p53-mediated transcription is the identity of an E3 Ub ligase. More than half a dozen of E3 Ub ligases have shown to target p53 for proteolysis. However, most of E3s have inhibitory effect on p53-mediated transcription except for topors (topoisomerase I-binding protein) (Lin et al., 2005; Brooks and Gu, 2006) . Topors have been shown to function as an E3 Ub ligase for p53 (Rajendra et al., 2004) . Besides, topers can associate with p53 and act as a co-activator for p53 in growth suppression induced by DNA damage (Lin et al., 2005) . These properties make topors a likely E3 Ub ligase candidate in the regulation of p53-mediated transcription by UPS. Interestingly, MDM2 cannot be excluded. For example, MDM2 is a positive regulator of human immunodeficiency virus transactivator Tat. MDM2 ubiquitylates Tat and enhances Tat-mediated transactivation (Bres et al., 2003) . Furthermore, MDM2 has been shown to recruit to the estrogen receptor-a-binding pS2 promoter (Reid et al., 2003) . As the nature of MDM2-mediated transcriptional activation and inhibition is not fully p53 Degradation in transcriptional activation Q Zhu et al understood, the role of MDM2 in p53 transactivation needs to be explicitly tested.
In summary, our results have revealed a positive regulatory role of UPS in p53-mediated transcription and the direct involvement of proteasome in such a regulation through p53-Sug-1 interaction. These observations open up an avenue in elucidating the role of UPS in p53-mediated transcription. Besides p53, histone H2B may be the alternate targets for regulation of p53-mediated transcription by UPS (Kim et al., 2005) . The exact context notwithstanding, ubiquitylation of transcription activators and histones may represent two inter-related modes of transcriptional regulation of gene expression in mammalian cells.
Materials and methods

Plasmid constructs
The p53 expression and reporter constructs were obtained from respective laboratories and are as originally described (Kern et al., 1992) . The constructs encoding GAL4 DNA BD fused with either p53 or N-terminus (1-42 aa) of p53 (Haupt et al., 1997) were provided by Dr Moshe Oren (Weizmann Institute of Science, Israel). Bacterial expression constructs for GST and GST-Sug-1 fusion proteins were constructed using pGEX-4T-1 vector (Amersham Pharmacia Biotech, Uppsala, Sweden). The Sug-1 and Sug-1m constructs were gifts from Jeffrey E Kudlow (University of Alabama at Birmingham, AL, USA).
Antibodies and biochemicals
The antibodies, Ab-2 and Ab-6 for detecting human p53 protein, Ab-1 for mouse p53 protein, anti-actin (Ab-5) antibodies as well as the anti-p21 waf1 monoclonal antibody Ab-5 (clone HZ52) for detecting mouse p21 waf1 protein, were obtained from Lab Version Corporation (Fremont, CA, USA). Anti-HA (12CA5) and anti-Myc (9E10) antibodies and FuGENE 6 transfection reagent were from Roche Molecular Biochemicals (Indianapolis, IN, USA). Monoclonal anti-GAL4 BD and anti-Sug-1 antibodies were purchased from BD Biosciences (San Jose, CA, USA). Rabbit polyclonal antibodies against proteasome 19S subunit S1 and TFIIH component XPB were respectively obtained from Affinity BioReagents (Golden, CO, USA) and Santa Cruz Biotechnology (Santa Cruz, CA, USA). The mouse Ub antibody, Protein G plus/protein A agarose beads, proteasome inhibitors MG132 and lactacystin were from Calbiochem (EMD Biosciences, Inc. San Diego, CA, USA). Formaldehyde, ActD, DRB and a-amanitin were all purchased from Sigma-aldrich (Sigma, St Louis, MO, USA). Protein A agarose/Salmon Sperm DNA for ChIP was product from Upstate Biotechnology (Upstate Biotechnology Inc., NY, USA).
Cell culture, transient transfection and luciferase report assay The NHF (p53-WT) were established in culture as described earlier (Venkatachalam et al., 1995) . LFS fibroblast strain, MDAH041 (p53 Null) was originally provided by Dr Michael Tainsky (MD Anderson Cancer center, Austin, TX, USA). Transient transfection was carried out in NHF, LFS (MDAH041) and HeLa cells at 371C or the mouse Ubactivating enzyme (E1) temperature-sensitive ts85 cell line at 321C as described earlier (Zhu et al., 2004) 
(Supplementary Information).
Western blotting and metabolic labeling analysis Cells were lysed by boiling for 10 min in sample buffer (2% sodium dodecyl sulfate (SDS), 10% glycerol, 10 mM dithiothreitol in 62 mM Tris-HCl, pH 6.8, 10 mg/ml pepstatin and 10 mg/ml leupeptin) and protein concentration was determined by DC Bio-Rad assay. Western blotting was performed using appropriate antibodies as described previously (Wani et al., 1999; Zhu et al., 2004) . To determine the endogenous p53 by metabolic labeling, ts85 cells were seeded at 5 Â 10 6 per 100 mm diameter dish at 321C (permissive temperature). After 24 h, the cells were incubated at 371C (restrictive temperature) or reincubated at 321C for 24 h. The cells were then washed twice with phosphate-buffered saline and maintained in methioninefree medium for 1 h and labeled with [
35 S] methionine at the concentration of 70 mCi/ml for 3 h. After labeling, the cells were collected and lysed in radioimmunoprecipitation assay (RIPA) buffer (2 mM Tris-HCl pH 7.5, 5 mM ethylenediaminetetraacetic acid, 150 NaCl, 0.5% Nonidet P-40, 1.0% deoxycholate, 0.025% SDS, 1 mM phenylmethylsulphonyl fluoride and a protease inhibitor cocktail) and the lysates were incubated for 1 h with anti-p53 antibody and for another 1 h with protein A/plus G agarose beads at 41C. The captured immunoprecipitates were recovered and subjected to SDS/ polyacrylamide gel electrophoresis (PAGE) gel electrophoresis and autoradiography.
Methodology for immunoprecipitation, GST pull-down, RT-PCR and ChIP assay are detailed in the 'Supplementary Information'.
